General Information of Drug (ID: DMNZSC1)

Drug Name
Candicidin Drug Info
Synonyms
(23E,25E,27E,29E,31E,33E,35E)-22-(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy-10,12,14,18,20-pentahydroxy-37-methyl-2,4,8,16-tetraoxo-1-oxacyclooctatriaconta-23,25,27,29,31,33,35-heptaene-19-carboxylic acid
Indication
Disease Entry ICD 11 Status REF
Bacterial infection 1A00-1C4Z Approved [1]
Therapeutic Class
Antibiotics
Cross-matching ID
PubChem CID
10079874
ChEBI ID
CHEBI:3349
CAS Number
CAS 1403-17-4
TTD Drug ID
DMNZSC1

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [3]
Nystatin DM63QS9 Cutaneous candidiasis 1F23.14 Approved [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fungal Cell membrane ergosterol (Fung CME) TTQKWA4 NOUNIPROTAC Modulator [2]

References

1 Drug information of Candicidin, 2008. eduDrugs.
2 Mode of Action of the Polyene Antibiotic Candicidin: Binding Factors in the Wall of Candida albicans
3 Comparative molecular dynamics simulations of amphotericin B-cholesterol/ergosterol membrane channels. Biochim Biophys Acta. 2002 Dec 23;1567(1-2):63-78.
4 Cholesterol and Ergosterol Influence Nystatin Surface Aggregation: Relation to Pore Formation